1. Sofosbuvir/velpatasvir fixed-dose combination for the treatment of chronic hepatitis C virus infection;Nehra;Drugs Today (Barc.),2017
2. Development and validation of three novel UV spectrophotometric methods for determination of newly discovered combination for the treatment of hepatitis C and their comparison using ANOVA;Reema;Int. J. Pharm. Drug Anal.,2018
3. Analytical method development and validation for the simultaneous estimation of sofosbuvir and velpatasvir drug product by reverse phase high performance liquid chromatography method;Nekkala;Asian J. Pharm. Clinic. Res.,2018
4. A stability indicating RP-HPLC method for simultaneous estimation of velpatasvir and sofosbuvir in combined tablet dosage forms;Nalla;World J Pharm. Pharm. Sci. (WJPPS),2017
5. Analytical method development and validation for the simultaneous estimation of sofosbuvir and velpatasvir drug product by RP-HPLC method;Jyothi;Indoamerican J. Pharm. Res. (IAJPR),2017